Condition (MeSH)
Leukemia, Basophilic, Acute
ClinicalTrials.gov lists 55 trials for Leukemia, Basophilic, Acute or a narrower condition beneath it. National Cancer Institute (NCI) has the most among industry and government lead sponsors, with 20.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
55 of the 55 trials are tagged with Leukemia, Basophilic, Acute itself; the rest are tagged with a narrower condition beneath it.
When did Leukemia, Basophilic, Acute trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 10
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2014 | 1 |
| 2012 | 3 |
| 2011 | 4 |
| 2010 | 4 |
| 2008 | 4 |
| 2007 | 1 |
| 2006 | 9 |
| 2005 | 9 |
| 2004 | 10 |
| 2002 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 55 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Leukemia, Basophilic, Acute trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 21 |
| Phase 1/2 | 1 |
| Phase 2 | 17 |
| Phase 2/3 | 2 |
| Phase 3 | 5 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 7 |
How many Leukemia, Basophilic, Acute trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 40 |
| Terminated | 7 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Leukemia, Basophilic, Acute trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Cancer Institute (NCI) | 20 |
| SWOG Cancer Research Network | 4 |
| Children's Oncology Group | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Vion Pharmaceuticals | 2 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Leukemia, Basophilic, Acute? (6)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| CLOFARABINE | 5 |
| Tipifarnib | 5 |
| Cytoxan | 4 |
| Mitoxantrone | 4 |
| Sorafenib | 3 |
Showing 5 of 6 drugs.
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Cytarabine IT | 22 |
| Daunorubicine | 8 |
| Filgrastime (G-CSF) | 6 |
| Idarubicina | 6 |
| Etoposid | 6 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Leukemia, Basophilic, Acute trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Hemoglobin decreased | 302 | 1 |
| Platelet count decreased | 301 | 1 |
| Neutrophil count decreased | 291 | 1 |
| Febrile neutropenia | 271 | 7 |
| Fatigue | 195 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Leukemia, Basophilic, Acute? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Proposed diagnostic criteria and classification of basophilic leukemias and related disorders. | Leukemia | 2017 | Yes |
| Inhibitory effects of adlay bran (Coix lachryma-jobi L. var. ma-yuen Stapf) on chemical mediator release and cytokine production in rat basophilic leukemia cells. | Journal of ethnopharmacology | 2012 | Yes |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Acute basophilic leukemia | Annual incidence | <1 / 1 000 000 | Europe | Not stated | Exact |
| Acute basophilic leukemia | Annual incidence | <1 / 1 000 000 | Europe | Not stated | Exact |
| Acute basophilic leukemia | Annual incidence | <1 / 1 000 000 | Europe | Not stated | Unspecified |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Acute basophilic leukemia | 86849 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Acute basophilic leukemia | 86849 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.